{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:32:40Z","timestamp":1790199160669,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jfo.2016.12.013","type":"journal-article","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T20:02:21Z","timestamp":1491249741000},"page":"430-437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["R\u00e9tinopathie du pr\u00e9matur\u00e9"],"prefix":"10.1016","volume":"40","author":[{"given":"V.","family":"Promelle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Milazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2016.12.013_bib0150","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1167\/iovs.08-2584","article-title":"Through the eyes of a child: understanding retinopathy through ROP the Friedenwald lecture","volume":"49","author":"Smith","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2016.12.013_bib0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","article-title":"Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control","volume":"84","author":"Gilbert","year":"2008","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.jfo.2016.12.013_bib0160","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/bjo.2007.126201","article-title":"Retinopathy of prematurity in the United States","volume":"92","author":"Lad","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.12.013_bib0165","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1542\/peds.2004-1309","article-title":"Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand Neonatal Network","volume":"115","author":"Darlow","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.jfo.2016.12.013_bib0170","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0181-5512(04)96138-4","article-title":"[Retinopathy of prematurity. Results of fundus examination performed in 94\u00a0preterm infants]","volume":"27","author":"Beby","year":"2004","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2016.12.013_bib0175","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1542\/peds.2012-2996","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"131","author":"Fierson","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.jfo.2016.12.013_bib0180","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/bjo.83.4.425","article-title":"Dopamine use is an indicator for the development of threshold retinopathy of prematurity","volume":"83","author":"Mizoguchi","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.12.013_bib0185","series-title":"Recommandations fran\u00e7aises pour le d\u00e9pistage de la r\u00e9tinopathie des pr\u00e9matur\u00e9s","author":"Barjol","year":"2015"},{"key":"10.1016\/j.jfo.2016.12.013_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaapos.2016.09.016","article-title":"Retinopathy of prematurity in Pakistan","author":"Sadiq","year":"2016","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.jfo.2016.12.013_bib0195","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/112067211002000417","article-title":"Retinopathy of prematurity: screening guidelines need to be reevaluated for developing countries","volume":"20","author":"Ba\u015fmak","year":"2010","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.12.013_bib0200","series-title":"ATROPINE ALCON 0.3\u00a0% collyre","author":"Commission de la transparence de la Haute Autorit\u00e9 de sant\u00e9","year":"2011"},{"key":"10.1016\/j.jfo.2016.12.013_bib0205","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5301\/ejo.5000540","article-title":"Efficacy and safety of phenylephrine 2.5\u00a0% with cyclopentolate 0.5\u00a0% for retinopathy of prematurity screening in 1246\u00a0eye examinations","volume":"25","author":"Neffendorf","year":"2015","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.12.013_bib0210","series-title":"NEOSYNEPHRINE 2.5\u00a0% FAURE collyre en solution en r\u00e9cipient unidose","author":"Commission de la transparence de la Haute Autorit\u00e9 de sant\u00e9","year":"2015"},{"key":"10.1016\/j.jfo.2016.12.013_bib0215","unstructured":"Agence Nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9. Utilisation des collyres mydriatiques en p\u00e9diatrie pour l\u2019obtention d\u2019une mydriase ou d\u2019une cyclopl\u00e9gie \u00e0 vis\u00e9e diagnostique n.d."},{"key":"10.1016\/j.jfo.2016.12.013_bib0220","first-page":"991","article-title":"The International Classification of Retinopathy of Prematurity revisited","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"10.1016\/j.jfo.2016.12.013_bib0225","first-page":"471","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results","volume":"106","author":"Cryotherapy for Retinopathy of Prematurity Cooperative Group","year":"1988","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"10.1016\/j.jfo.2016.12.013_bib0230","first-page":"1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","author":"Early Treatment For Retinopathy Of Prematurity Cooperative Group null","year":"2003","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"10.1016\/j.jfo.2016.12.013_bib0235","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ophtha.2012.01.003","article-title":"Current role of cryotherapy in retinopathy of prematurity: a report by the American Academy of Ophthalmology","volume":"119","author":"Simpson","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2016.12.013_bib0240","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfo.2016.12.013_bib0245","article-title":"Long-term functional results following vitrectomy for advanced retinopathy of prematurity","author":"Karacorlu","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.12.013_bib0250","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00417-008-0786-7","article-title":"Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity","volume":"246","author":"Honda","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2016.12.013_bib0255","first-page":"931","article-title":"Paradoxical vascular-fibrotic reaction after intravitreal bevacizumab for retinopathy of prematurity","volume":"24","author":"Zepeda-Romero","year":"2010","journal-title":"Eye Lond Engl"},{"key":"10.1016\/j.jfo.2016.12.013_bib0260","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0161-6420(96)30647-7","article-title":"Visual acuity of eyes after vitrectomy for retinopathy of prematurity: follow-up at 5 1\/2\u00a0years","volume":"103","author":"Quinn","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2016.12.013_bib0265","first-page":"24","article-title":"Outcome of eyes developing retinal detachment during the Early Treatment for Retinopathy of Prematurity Study (ETROP)","volume":"124","author":"Repka","year":"2006","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"10.1016\/j.jfo.2016.12.013_bib0270","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJM199805283382202","article-title":"Lack of efficacy of light reduction in preventing retinopathy of prematurity","volume":"338","author":"Reynolds","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfo.2016.12.013_bib0275","doi-asserted-by":"crossref","first-page":"e1576","DOI":"10.1542\/peds.2015-2372","article-title":"Human milk feeding as a protective factor for retinopathy of prematurity: a meta-analysis","volume":"136","author":"Zhou","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.jfo.2016.12.013_bib0280","unstructured":"Target ranges of oxygen saturation in extremely preterm infants. - PubMed - NCBI n.d. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20472937 [accessed January 23, 2016]."},{"key":"10.1016\/j.jfo.2016.12.013_bib0285","doi-asserted-by":"crossref","DOI":"10.1007\/s10792-016-0176-9","article-title":"The macular findings on spectral-domain optical coherence tomography in premature infants with or without retinopathy of prematurity","author":"Gursoy","year":"2016","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jfo.2016.12.013_bib0145","first-page":"1","article-title":"R\u00e9tinopathie du pr\u00e9matur\u00e9","volume":"14","author":"Promelle","year":"2017","journal-title":"EMC Ophtalmologie"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551217300918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551217300918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:06:52Z","timestamp":1759259212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551217300918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0181551217300918"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2016.12.013","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"R\u00e9tinopathie du pr\u00e9matur\u00e9","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2016.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}